from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2343c/dnaG

LFCtreatmentdescriptionclass of inhibitor

-0.008

Amikacinug/mL Amikacintranslation

0.200

Cap5-10ug/mL Capreomycintranslation

0.499

Rox10-50 ug/mL Roxithromycintranslation

-0.453

SM2-5 ug/mL Streptomycintranslation

-0.386

Tet5-10 ug/mL Tetracyclinetranslation

1.808

Rif0.2-5ug/mL Rifampicintranscription

-0.254

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.656

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.036

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.192

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.216

Clofazimine10-13 ug/mL Clofaziminerespiration

0.442

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.807

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.006

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.248

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.336

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.514

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.024

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.434

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.186

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.036

KCN5-20 ug/mL Potassium cyaniderespiration

0.388

NaN30.2-2 mM Sodium aziderespiration

-0.119

Nigericin50 uM Nigericinrespiration

-0.169

TRC10-150 ug/mL Triclosanrespiration

-0.143

TRZ10-25 ug/mL Thioridazinerespiration

-1.221

Valinomycin0.5-10 uM Valinomycinrespiration

2.000

ZnSO42 mM ZnSO4respiration

0.242

menadione6-10 ug/mL Menadionerespiration

-0.274

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.249

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.708

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.447

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.034

NRP_1Non-replicating persistence stage 1dosRassociated

-0.029

Amp0.2mg/mL AmpicillincellWall

0.002

Cephalexin20-100 ug/mL CephalexincellWall

-0.107

Cerulenin0.32-5 ug/mL CerulenincellWall

1.014

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.217

EMB10-20 ug/mL EthambutolcellWall

0.577

Eta12-40 ug/mL EthionamidecellWall

0.464

INH0.2-0.4 ug/mL IsoniazidcellWall

1.036

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.128

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.321

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.077

BZA0.12 mg/mL BenzamidearomaticAmides

-0.634

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.877

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.542

H2O24 mM hydrogen peroxideDNAdamaging

-0.450

Levo10 ug/mL LevofloxacinDNAdamaging

-0.097

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.020

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.231

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.270

UVUV-irradiationDNAdamaging

0.471

ARP41-4 ug/mL Antitubercular compound ARP4?

0.484

Antimycin12.5-50 ug/mL Antimycin A?

-0.171

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.975

PA_110-50 ug/mL Antitubercular compound PA-1?

0.736

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.632

PA8240.2-2 ug/mL PA-824?

-0.882

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.226

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.121

Verapamil50 uM Verapamil?

-0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.142

methoxatin10-20 ug/mL Methoxatin?